FDA Approves Fourth ALK Inhibitor for Lung Cancer
Last week, a flurry of U.S. Food and Drug Administration (FDA) oncology approvals concluded with the approval of the...
Tag: Non-small cell lung cancer
Last week, a flurry of U.S. Food and Drug Administration (FDA) oncology approvals concluded with the approval of the...
Clinical trials are an essential part of cancer research. They ensure that scientific discoveries are translated into advances in...
As lung cancer awareness month drew to a close, the U.S. Food and Drug Administration (FDA) added another therapeutic...
Late last week, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of the...
On the heels of the U.S. Food and Drug Administration’s approval of a combination of immune checkpoint inhibitors for...
Immunotherapeutics called PD-1 inhibitors have garnered a lot of attention in the past year thanks to exciting clinical trial...
Guest Post by Dario C. Altieri, MD The Wistar Institute
The field of cancer immunotherapy broke new ground last week when the U.S. Food and Drug Administration (FDA) announced...